DelMar Pharmaceuticals, Inc.
2 clinical trials · Sponsor
◉ Watch DelMar Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM (NCT03149575) | DelMar Pharmaceuticals, Inc. | 2017-10-27 |
Track DelMar Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.